Veeva Systems stock has had a difficult longer term run, with the share price down about 39% over the past 5 years, while the current valuation signals send mixed messages. The intrinsic value estimate based on a Discounted Cash Flow (DCF) model points to meaningful upside compared with the current price, while market multiples suggest the stock screens as expensive.

• Over 5 years the share price has declined about 39%, which means recent investors are still carrying material capital losses despite shorter term gains.
• Valuation can be supported if Veeva Systems keeps converting its software revenues into steady cash flows, although any slowdown in customer adoption or pricing power may weigh directly on the intrinsic value.
• The stock currently earns a mixed valuation verdict, with Veeva Systems screening as undervalued on some checks but expensive on others, and only 3 of 6 checks passed according to the broader framework on this valuation score.

The stock's next move may depend on whether investors give more weight to the Discounted Cash Flow intrinsic value estimate that points to upside, or to the market multiples that suggest Veeva Systems is already pricing in a lot of good news.

Is Veeva Systems a Bargain on Cash Flow?

The Discounted Cash Flow model estimates what Veeva Systems could be worth based on the cash it is expected to generate for shareholders over time. For Veeva Systems, the latest twelve month free cash flow is about $1.64b, which is treated as growing over the forecast period in the model.

On these cash flow projections, the 2 Stage Free Cash Flow to Equity model points to an estimated intrinsic value of about $297 per share. Compared with the current share price, that implies the stock trades at roughly a 30.1% discount and appears undervalued based on this method.

On the DCF numbers alone, Veeva Systems stock appears undervalued relative to its projected cash generation.

Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 30.1%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.

Does Veeva Systems Look Pricey on Earnings?

The price-to-earnings (P/E) ratio is a useful cross-check for Veeva Systems because it ties the share price directly to the earnings that shareholders see today. Veeva Systems currently trades on a P/E of about 35.9x, compared with an average of 26.8x for the wider Healthcare Services industry and around 38.4x for its peer group. That puts the stock at a premium to the sector but slightly below the peer cluster.

The tailored fair P/E multiple for Veeva Systems, which adjusts for factors such as size, margins and risk, is about 30.4x. This is meaningfully below the current 35.9x level. The gap suggests investors are paying a higher price for each dollar of earnings than this framework would imply, even after allowing for the company’s specific characteristics.

On the P/E multiple, Veeva Systems stock screens as overvalued compared with the modelled fair ratio.

The Veeva Systems Narrative: What Would Justify Today's Price?

For Veeva Systems, Simply Wall St Narratives sit between the discounted cash flow upside and the richer P/E multiple by spelling out which paths for growth, margins and earnings would need to hold for the stock to be worth materially more or less than today’s price on the Community page. Each Narrative presents Veeva Systems' fair value as a thesis about the business that you can track over time rather than a one off snapshot.

Community views on Veeva Systems sit far apart, with one camp focused on durable workflows and another worried about AI and CRM pressure.

Bull case: 35% undervalued

"Veeva’s advantage is not that it invented AI. Its advantage may be that it already owns the workflow layer where AI can become useful…"

Bear case: 26% overvalued

"Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high…"

Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!

The Bottom Line

For Veeva Systems, the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while the market multiple view flags the stock as overvalued on earnings. That split often comes down to how much weight you put on long term cash generation versus what you are willing to pay today for growth and sentiment. Broader valuation checks sit in the middle and do not strongly support either extreme. The real swing factor from here is whether Veeva Systems can keep turning its software position into reliable cash flows that justify both the intrinsic value case and the current P/E premium.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.